Association of Galectin 9 Expression with Immune Cell Infiltration, Programmed Cell Death Ligand-1 Expression, and Patient’s Clinical Outcome in Triple-Negative Breast Cancer

Galectin-9 (Gal-9) is an immune checkpoint protein that facilitates T cell exhaustion and modulates the tumor-associated microenvironment, and could be a potential target for immune checkpoint inhibition. This study was conducted to assess Gal-9 expression in triple-negative breast cancer (TNBC) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Mi-Ha, Byun, Kyung-Do, Park, Eun-Hwa, Lee, Jin-Hwa, Han, Song-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533056/
https://www.ncbi.nlm.nih.gov/pubmed/34680500
http://dx.doi.org/10.3390/biomedicines9101383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533056/
https://www.ncbi.nlm.nih.gov/pubmed/34680500
http://dx.doi.org/10.3390/biomedicines9101383

Ejemplares similares